medline.ch Onkologie Gynäkologische Tumoren

	Cardiovascular events and mortality after breast cancer diagnosis: multistate models in a nationwide cohort study. BMJ Open Tvete IF, Klemp M. PMID: 42778238 [PubMed - indexed for MEDLINE]
	Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study. Breast Uyar GC, Ba, Oruç A, Majidova N, Akdo, Ye, Bir Yücel K, Karakurt Ery, Sütcüo, Çakmak Öksüzo, Alt. PMID: 42777557 [PubMed - as supplied by publisher]
	Improved overall survival with combined adjuvant chemotherapy and radiation in stage I uterine carcinosarcoma: A national cancer database study. Eur J Obstet Gynecol Reprod Biol Polio A, Esposito A, Bosquet JG, Goodheart MJ, Wagner VM. PMID: 42777469 [PubMed - as supplied by publisher]
	Comment on "Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study", Cheptea C, Kirova Y, Fourquet A, Loap P. Cancer Radiother 2026;30:104828. Cancer Radiother Ayoub Z, Al Bitar T, Eid T. PMID: 42777299 [PubMed - as supplied by publisher]
	Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study. Eur J Cancer Bernard-Tessier A, Spanggaard I, Utriainen T, Tanner M, Rohrberg K, Naoun N, Ikonen T, Pohjanjousi P, Garratt C, Poehlein C, Fizazi K. PMID: 42777289 [PubMed - as supplied by publisher]
	Exploring Primary Care Interventions to Increase Lung, Breast, and Cervical Cancer Screening With Individuals Experiencing Marginalization: A Scoping Review. Cancer Control Jantzen E, Quiambao JA, LeBlanc D, Cernat A, Calleja S, Tinmouth J, Lofters AK, Ruco A. PMID: 42777132 [PubMed - indexed for MEDLINE]
	Consecutive Negative Screening Tests for Ovarian Cancer: A Reliable Basis for Reassurance of Low Ovarian Cancer Mortality Risk? J Prev (2022) Jang J, Bae JK, Kim J, Kim U, Kang S. PMID: 42776419 [PubMed - as supplied by publisher]
	Breast cancer recurrence: socioeconomic position and general practice involvement - a nationwide cohort study in Denmark. Scand J Prim Health Care Godsk AC, Grooss K, Rasmussen LA, Falborg AZ, Vedsted P. PMID: 42776143 [PubMed - indexed for MEDLINE]
	Baseline Quality of Life and Its Predictors among Jordanian Women with Breast Cancer: Findings from an Ongoing Randomized Controlled Trial. Eur J Breast Health AlDaieflih M, Younis M, Shennar JA, Abdallah FM, AlGhawadreh A, Miqdadi A, Aldiqs M, Alhusamiah B, Al-Quran S. PMID: 42775970 [PubMed]
	Epigenetic control of cellular plasticity in breast cancer progression. FEBS J Massey EJ, Podleszanski E, Muller WJ. PMID: 42775899 [PubMed - as supplied by publisher]
	Effect of Surgical Delay After Neoadjuvant Chemotherapy on Survival Outcomes in Breast Cancer: A Systematic Review and Meta-Analysis. Eur J Breast Health Gallego GMV, Ordoñez FCR. PMID: 42775859 [PubMed]
	Dosimetric evaluation of systematic source position uncertainty along the source path and robust planning during MRI-only cervical HDR brachytherapy. J Appl Clin Med Phys Singh A, Karshafian R, Ravi A, Paudel MR. PMID: 42775606 [PubMed - indexed for MEDLINE]
	Leveraging digital pathology to enhance breast cancer diagnosis in low-resource settings: a cross-sectional study of major histopathology laboratories in Uganda. Oxf Open Digit Health Semwanga AR, Serubugo J, Kiberu VM, Nalwoga H, Kahiigi EK, Tumwesigye NM, Kalungi S. PMID: 42775178 [PubMed]
	Circulating and tumor-infiltrating immune cell profiles in cervical cancer checkpoint blockade: multi-omics biomarkers of response and resistance. Front Immunol Li W, Yu X, Wei W, Wang Y, Zhang S, Aziz AUR, Wang D, Ha C. PMID: 42774775 [PubMed - indexed for MEDLINE]
	Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer. Front Oncol Pawul W, Opoka P, Dusza A, Blajerski B, Orzelska J, Gierulska N, Ku, Tarkowski R. PMID: 42774753 [PubMed]
	Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncology. Oncol Rev Obeagu EI. PMID: 42774746 [PubMed]
	Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review. Front Immunol McGillivray E, Kane S, Saadatkhah A, Yeung KT. PMID: 42774612 [PubMed - indexed for MEDLINE]
	Fertility-sparing surgery for a patient with a pre-operative suspected diagnosis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A case report. Gynecol Oncol Rep Kipp MP, Roecker ZA, Mashayekhi A, Scalici JM, Ramirez-Caban LC. PMID: 42774574 [PubMed]
	Perfusion response to treatment outcome: CEUS links oxytocin to HIFU efficacy prediction for uterine fibroids. Int J Hyperthermia Zhang DL, Wu S, Ding G, Chen XW, Chen M, Chen S. PMID: 42773797 [PubMed - indexed for MEDLINE]
	PD-L1 Expression in Uterine Mesenchymal Tumors: A Comparative Immunohistochemical Analysis. J Obstet Gynaecol Res Bahitli FM, Akman L, Serin G, Acar M, Yildirim N, Zekioglu O, Terek MC, Goker E, Ozsaran AA. PMID: 42773568 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 335516

Seite 1 von 16776

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung